First leukemia patient dosed with SMART101
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101, a T-cell progenitor cell injection.
Source: labiotech.eu
Stay updated with breaking news from Protcellt Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101, a T-cell progenitor cell injection.
First US leukemia patient dosed with Smart Immune’s investigational SMART101 cell therapy - read this article along with other careers information, tips and advice on BioSpace